1. Home
  2. Analysis
  3. Sprycel
  4. Heart-rate-decreased

Sprycel and Heart rate decreased - a phase IV clinical study of FDA data

Summary:

Heart rate decreased is reported as a side effect among people who take Sprycel (dasatinib), especially for people who are female, 60+ old, also take Gleevec, and have Chronic myelomonocytic leukaemia.

The phase IV clinical study analyzes which people have Heart rate decreased when taking Sprycel. It is created by eHealthMe based on reports of 29,638 people who have side effects when taking Sprycel from the FDA, and is updated regularly.

What is Sprycel?

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.

What is Heart rate decreased?

Heart rate decreased is found to be associated with 1,548 drugs and 1,599 conditions by eHealthMe. Check the latest studies of Heart rate decreased.

On Jul, 19, 2026

29,638 people reported to have side effects when taking Sprycel.
Among them, 15 people (0.05%) have Heart rate decreased.

Could Sprycel cause Heart rate decreased?

Among these 15 people:

What is the gender of people who have Heart rate decreased when taking Sprycel? *

  • female: 60 %
  • male: 40 %

What is the age of people who have Heart rate decreased when taking Sprycel? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 20 %
  • 60+: 80 %

What are other drugs people take besides Sprycel? *

  1. Tasigna: 2 people, 13.33%
  2. Iclusig: 2 people, 13.33%
  3. Gleevec: 2 people, 13.33%
  4. Zofran: 1 person, 6.67%
  5. Vitamins: 1 person, 6.67%
  6. Rosuvastatin Calcium: 1 person, 6.67%
  7. Prograf: 1 person, 6.67%
  8. Multivitamin: 1 person, 6.67%
  9. Methotrexate: 1 person, 6.67%
  10. Imitrex: 1 person, 6.67%

What are other side effects people have besides Heart rate decreased? *

  1. High Blood Pressure: 5 people, 33.33%
  2. Pain In Extremity: 5 people, 33.33%
  3. Pneumonia: 4 people, 26.67%
  4. White Blood Cell Count Decreased: 3 people, 20.00%
  5. Oedema Peripheral (superficial swelling): 3 people, 20.00%
  6. Weight Increased: 3 people, 20.00%
  7. Joint Pain: 3 people, 20.00%
  8. Joint Swelling: 3 people, 20.00%
  9. Fever: 3 people, 20.00%
  10. Febrile Neutropenia (fever with reduced white blood cells): 3 people, 20.00%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
  2. Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Sprycel and have Heart rate decreased?

- Check whether Heart rate decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sprycel:

Heart rate decreased treatments and more:

How severe was Heart rate decreased and when was it recovered:

Expand to all the drugs that have ingredients of dasatinib:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sprycel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart rate decreased:

Browse all the conditions that are associated with Heart rate decreased:

How the study uses the data?

The study uses data from the FDA. It is based on dasatinib (the active ingredients of Sprycel) and Sprycel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.